Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries for protein-protein interfaces.
Fig. 1. The sreening workflow of Receptor.AI
The method includes extensive molecular simulations of the target protein alone and in complex with its most relevant partner proteins, followed by ensemble virtual screening that considers conformational mobility in both free and complex states. Potential binding pockets are examined on the protein-protein interaction interface and in distant allosteric sites to cover all possible mechanisms of action.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q13158
UPID:
FADD_HUMAN
Alternative names:
FAS-associating death domain-containing protein; Growth-inhibiting gene 3 protein; Mediator of receptor induced toxicity
Alternative UPACC:
Q13158; Q14866; Q6IBR4
Background:
The FAS-associated death domain protein, also known as FAS-associating death domain-containing protein, Growth-inhibiting gene 3 protein, and Mediator of receptor induced toxicity, plays a crucial role in apoptosis. It recruits caspase-8 or caspase-10 to activated receptors, forming a complex that initiates the cascade of caspases mediating cell death. Additionally, it is involved in antiviral immune responses by positively regulating interferon signaling.
Therapeutic significance:
Linked to a condition characterized by autoimmune features, recurrent fever, encephalopathy, and liver dysfunction, understanding the role of FAS-associated death domain protein could open doors to potential therapeutic strategies. Its involvement in apoptosis and immune response highlights its potential as a target in treating related diseases.